Company & Sponsor Intelligence
Centre Hospitalier St Anne
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting3
Completed0
Countries1
Therapeutic footprint
adhddepressionepilepsyother_psychiatryout_of_scope
Indexed studies
NCT05182515Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies
out_of_scope · FrancePHASE3
out_of_scope · FrancePHASE3
NCT07652788Efficacy of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
adhd · NA
adhd · NA
NCT07544563Phenotypic Exploration During Sensory Stimulation in an Acoustic Chamber
epilepsy · FranceRECRUITING
epilepsy · FranceRECRUITING
NCT07144943"Evolution of Sexual Symptoms in Paraphilic Sexual Offenders With/Without Antiandrogen or SSRI Treatment"
other_psychiatry · NOT_YET_RECRUITING
other_psychiatry · NOT_YET_RECRUITING
NCT02378818Characterization of the Motivational Deficit in Schizophrenia and Depression
depression · FranceNA
depression · FranceNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →